Charles River Laboratories CRL Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's stock-based comp?
- Charles River Laboratories (CRL) reported stock-based comp of $22.38M in Q1 2026.
- How has Charles River Laboratories's stock-based comp changed year-over-year?
- Charles River Laboratories's stock-based comp increased by 70.4% year-over-year, from $13.14M to $22.38M.
- What is the long-term trend for Charles River Laboratories's stock-based comp?
- Over 4 years (2021 to 2025), Charles River Laboratories's stock-based comp has grown at a -0.1% compound annual growth rate (CAGR), from $71.47M to $71.08M.
- What does stock-based comp mean?
- The cost of paying employees with company stock instead of cash.
- How do you interpret stock-based comp?
- Rising levels may indicate aggressive talent retention strategies or increased dilution for existing shareholders.
- How does stock-based comp compare across companies?
- Standard in the life sciences and tech sectors; investors compare this as a percentage of revenue across peers.